NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
07 nov. 2023 08h50 HE
|
NeuroSigma, Inc.
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its second-generation...
Global Single-Cell Multi-Omics Market Size to Surge to USD 8.98 Billion by 2030, Fueled by Technological Breakthroughs and Pharmaceutical Growth
07 nov. 2023 08h30 HE
|
Straits Research
New York, United States, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Single-cell multi-omics analyses multiple molecules from a single cell to gather more biological knowledge than studying each molecular...
Diagnostic Imaging Market revenue to surpass USD 240 Billion by 2036, says Research Nester
07 nov. 2023 06h30 HE
|
Research Nester
New York , Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global diagnostic imaging market size is projected to grow at a CAGR of over 6% from 2024 to 2036. The market is expected to garner a revenue of USD...
Contrast Media Market revenue to cross USD 13 Billion by 2035, says Research Nester
07 nov. 2023 06h00 HE
|
Research Nester
New York , Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global contrast media market size is predicted to expand at 6.70% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD 13...
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
02 nov. 2023 08h30 HE
|
PaxMedica, Inc.
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has...
Groundbreaking study reveals link between air pollution and incidence of Parkinson’s disease
31 oct. 2023 18h07 HE
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
Phoenix, Oct. 31, 2023 (GLOBE NEWSWIRE) -- A new study led by researchers at Barrow Neurological Institute has found that people living in regions with median levels of air pollution have a 56...
Allyx Therapeutics Lead Compound ALX-001 is Safe and Tolerable at Doses, Achieving Full Brain Target Engagement in Healthy Older Adults
30 oct. 2023 08h30 HE
|
Allyx Therapeutics Inc.
Allyx Therapeutics Phase 1a Clinical Data Presented at Clinical Trials on Alzheimer's Disease Meeting Support Continued Clinical Development
Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo
30 oct. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Embolization Coils Market revenue to cross USD 3 Billion by 2035, says Research Nester
26 oct. 2023 06h30 HE
|
Research Nester
New York , Oct. 26, 2023 (GLOBE NEWSWIRE) -- The global embolization coils market size is estimated to attain at 6% CAGR from 2023 to 2035. The market is expected to garner a revenue of USD 3...
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
20 oct. 2023 12h58 HE
|
UsAgainstAlzheimer's
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...